Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Reversing the undesirable pH-profile of doxorubicin via activation of a disubstituted maleamic acid prodrug at tumor acidity

US Patent 12285437 · Granted Apr 29, 2025

Assignee

Inventors

View full patent text on Google Patents →